Playlist


Turkmenistan Showcases National Heritage at K-Modest Fashion Show in Seoul
02 Apr. 08:39The Embassy of Turkmenistan in the Republic of Korea presented a dedicated national exhibition pavilion as part of the K-Modest Fashion Show international event. Hosted at the renowned Dongdaemun Design Plaza (DDP), the pavilion served as a cultural bridge, introducing the South Korean public and international guests to the artistic traditions of the Turkmen people. The showcase highlighted the intersection of historical identity and contemporary aesthetics.
The exhibition featured an extensive collection of authentic artifacts, including traditional garments, exquisite hand-woven carpets, and intricate jewelry pieces. These items collectively illustrated the depth of Turkmen craftsmanship and the enduring nature of its cultural symbols. Visitors had the opportunity to observe the meticulous techniques and symbolic patterns that define the nation’s decorative and applied arts.
A significant highlight of the pavilion was the display of literary works authored by the President of Turkmenistan and the National Leader of the Turkmen people, Chairman of the Halk Maslakhaty. These publications provided comprehensive insights into the country’s history, social philosophy, and strategic development goals. The literary corner offered a scholarly perspective to complement the visual richness of the textile and craft displays.
Participating in such high-profile international fashion and cultural forums strengthens the bilateral ties between Turkmenistan and the Republic of Korea. By presenting its heritage in a global creative hub like Seoul, Turkmenistan continues to promote its cultural diplomacy and enhance its visibility on the world stage. The event successfully fostered cross-cultural dialogue and appreciation for Central Asian artistic excellence.
Also read


Simple Vitamin Shows Surprising Results in Pre-Cancerous Blood Conditions, Study Finds
Today in 02:02Daily high-dose supplementation of vitamin C can significantly reduce mortality risks and help prevent severe medical complications in patients with pre-cancerous blood conditions. Researchers from the Van Andel Institute in the United States and Copenhagen University Hospital in Denmark reached this conclusion following a comprehensive three-year follow-up study. The international "EVITA" trial involved volunteers who were administered 1,000 mg of vitamin C daily over the course of a year, while a control group received a placebo.
Although initial hypotheses suggested vitamin C might directly inhibit abnormal cell proliferation, researchers found its primary benefit lay in strengthening the body, reducing systemic inflammation, and lowering rates of anemia, pneumonia, and internal bleeding. Over the three-year observation period, the vitamin C group exhibited a significantly higher survival rate compared to the placebo group. While experts emphasize that these findings remain preliminary and require larger clinical trials before reshaping formal medical treatment protocols, vitamin C continues to show promising potential in supportive patient care.